Peptide Research Guide
Peptides are short chains of amino acids. Some peptide-based medicines are FDA approved for specific medical uses, while many compounds discussed online remain investigational, unapproved, or supported mainly by preclinical research. This section separates those categories and tracks the quality of evidence behind popular peptide topics.
FDA-approved peptide medicines vs. research peptides
The word peptide describes a broad class of molecules, not a regulatory category. Some peptide medicines have been reviewed and approved by the FDA for defined indications. Other compounds are being studied in clinical trials, and others have only laboratory or animal evidence. We label these differences throughout the library rather than treating all peptides as interchangeable.
How we rate evidence
| Evidence level | What it means |
|---|---|
| Established clinical use | Approved medicine or substantial human clinical evidence for a defined use. |
| Human research | Published human studies exist, but conclusions may remain limited or indication-specific. |
| Early clinical / investigational | Clinical development is ongoing; safety and efficacy are not established for general use. |
| Preclinical | Evidence is primarily laboratory or animal research. |
Popular research topics
Start with retatrutide, BPC-157, TB-500, MOTS-C, and GHK-Cu.